Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· March 24, 2026

0G Labs Trained World's Largest Decentralized AI Model at 107B Parameters in 2025 - Eight Months Before This Week's Industry Headlines

View original at globenewswire.com
0G Labs Trained World's Largest Decentralized AI Model at 107B Parameters in 2025 - Eight Months Before This Week's Industry Headlines San Francisco, CA, March 24, 2026 (GLOBE NEWSWIRE) -- While the crypto industry celebrated Bittensor's Covenant-72B this week as a breakthrough in decentralized AI training, 0G Labs had…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • While the industry celebrated Bittensor's 72B model this week, 0G had already trained 107B parameters in July 2025 - 48% larger, 8 months earlier

    60% confidence
  • This isn't about breaking records, it's about building AI as a public good

    60% confidence
  • We proved decentralized infrastructure can train a 107 billion parameter model in 2025, before anyone else

    60% confidence
  • 0G's approach achieves approximately 95% cost reduction compared to centralized GPU cluster training

    60% confidence
  • This week's headlines celebrating 72 billion parameters as a milestone missed that 0G had already operated at significantly larger scale

    60% confidence
  • 0G set the benchmark for decentralized AI training on standard consumer bandwidth

    60% confidence
  • The industry is finally paying attention to decentralized AI

    60% confidence
  • Distributed, open-source AI training is complementary to centralized approaches and will play a growing role in frontier model development

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com